NasdaqGM - Nasdaq Real Time Price USD
Biodesix, Inc. (BDSX)
0.5712
+0.0760
+(15.35%)
At close: April 24 at 4:00:01 PM EDT
0.5937
+0.02
+(3.94%)
After hours: April 24 at 7:54:41 PM EDT
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 1,206,460 | 21 |
| Sales | 152,032 | 10 |
| Net Shares Purchased (Sold) | 1,054,428 | 31 |
| Total Insider Shares Held | 70.73M | -- |
| % Net Shares Purchased (Sold) | 1.50% | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| FRANCHI JEAN M Director | -- | Direct | -- | Apr 1, 2025 |
| PATIENCE JOHN Chairman of the Board | -- | Direct | -- | Mar 31, 2025 |
| WATTS CHARLES MCDONALD Director | -- | Direct | -- | Mar 31, 2025 |
| HUTTON SCOTT Chief Executive Officer | Sale at price 0.92 per share. | Direct | 77,319 | Feb 11, 2025 |
| O'KANE KIERAN Officer | Sale at price 0.92 per share. | Direct | 16,198 | Feb 11, 2025 |
| COWIE ROBIN HARPER Chief Financial Officer | Sale at price 0.92 per share. | Direct | 22,794 | Feb 11, 2025 |
| PESTANO GARY ANTHONY Officer | Sale at price 0.92 per share. | Direct | 15,479 | Feb 11, 2025 |
| VAZQUEZ CHRISTOPHER Officer | Sale at price 0.92 per share. | Direct | 3,355 | Feb 11, 2025 |
| HUTTON SCOTT Chief Executive Officer | -- | Direct | -- | Feb 10, 2025 |
| O'KANE KIERAN Officer | -- | Direct | -- | Feb 10, 2025 |
| COWIE ROBIN HARPER Chief Financial Officer | -- | Direct | -- | Feb 10, 2025 |
| PESTANO GARY ANTHONY Officer | -- | Direct | -- | Feb 10, 2025 |
| VAZQUEZ CHRISTOPHER Officer | -- | Direct | -- | Feb 10, 2025 |
| SCHULER JACK W Director and Beneficial Owner of more than 10% of a Class of Security | Purchase at price 1.23 per share. | Indirect | 122,840 | Nov 21, 2024 |
| KENNEDY LAWRENCE T JR. Director and Beneficial Owner of more than 10% of a Class of Security | Purchase at price 1.16 per share. | Indirect | 40,562 | Nov 21, 2024 |
| SCHULER JACK W Director and Beneficial Owner of more than 10% of a Class of Security | Purchase at price 1.17 per share. | Indirect | 234,000 | Nov 20, 2024 |
| HUTTON SCOTT Chief Executive Officer | Sale at price 1.39 - 1.40 per share. | Direct | 5,220 | Nov 12, 2024 |
| O'KANE KIERAN Officer | Sale at price 1.39 - 1.40 per share. | Direct | 645 | Nov 12, 2024 |
| COWIE ROBIN HARPER Chief Financial Officer | Sale at price 1.39 - 1.40 per share. | Direct | 1,355 | Nov 12, 2024 |
| PESTANO GARY ANTHONY Officer | Sale at price 1.39 - 1.40 per share. | Direct | 596 | Nov 12, 2024 |
| VAZQUEZ CHRISTOPHER Officer | Sale at price 1.39 - 1.40 per share. | Direct | 283 | Nov 12, 2024 |
| HUTTON SCOTT Chief Executive Officer | -- | Direct | -- | Nov 8, 2024 |
| O'KANE KIERAN Officer | -- | Direct | -- | Nov 8, 2024 |
| COWIE ROBIN HARPER Chief Financial Officer | -- | Direct | -- | Nov 8, 2024 |
| PESTANO GARY ANTHONY Officer | -- | Direct | -- | Nov 8, 2024 |
| VAZQUEZ CHRISTOPHER Officer | -- | Direct | -- | Nov 8, 2024 |
| KENNEDY LAWRENCE T JR. Director and Beneficial Owner of more than 10% of a Class of Security | Purchase at price 1.36 per share. | Indirect | 97,068 | Nov 6, 2024 |
| SCHULER JACK W Director and Beneficial Owner of more than 10% of a Class of Security | Purchase at price 1.36 per share. | Indirect | 136,585 | Nov 5, 2024 |
| PATIENCE JOHN Chairman of the Board | Purchase at price 1.38 per share. | Indirect | 103,710 | Nov 5, 2024 |
| MASSARANY HANY Director | Purchase at price 1.37 per share. | Indirect | 30,866 | Nov 5, 2024 |
| STROBECK MATTHEW Director | Purchase at price 1.40 per share. | Indirect | 55,916 | Nov 5, 2024 |
| HUTTON SCOTT Chief Executive Officer | Sale at price 1.57 - 1.60 per share. | Direct | 5,966 | Aug 12, 2024 |
| O'KANE KIERAN Officer | Sale at price 1.57 - 1.60 per share. | Direct | 741 | Aug 12, 2024 |
| COWIE ROBIN HARPER Chief Financial Officer | Sale at price 1.57 - 1.60 per share. | Direct | 1,554 | Aug 12, 2024 |
| PESTANO GARY ANTHONY Officer | Sale at price 1.57 - 1.60 per share. | Direct | 687 | Aug 12, 2024 |
| VAZQUEZ CHRISTOPHER Officer | Sale at price 1.57 - 1.60 per share. | Direct | 333 | Aug 12, 2024 |
| HUTTON SCOTT Chief Executive Officer | -- | Direct | -- | Aug 8, 2024 |
| O'KANE KIERAN Officer | -- | Direct | -- | Aug 8, 2024 |
| COWIE ROBIN HARPER Chief Financial Officer | -- | Direct | -- | Aug 8, 2024 |
| PESTANO GARY ANTHONY Officer | -- | Direct | -- | Aug 8, 2024 |
| VAZQUEZ CHRISTOPHER Officer | -- | Direct | -- | Aug 8, 2024 |
| WATTS CHARLES MCDONALD Director | -- | Direct | -- | Jul 16, 2024 |
| HUTTON SCOTT Chief Executive Officer | -- | Direct | -- | May 23, 2024 |
| SCHULER JACK W Director and Beneficial Owner of more than 10% of a Class of Security | -- | Indirect | -- | May 23, 2024 |
| PATIENCE JOHN Chairman of the Board | -- | Indirect | -- | May 23, 2024 |
| STROBECK MATTHEW Director | -- | Indirect | -- | May 23, 2024 |
| O'KANE KIERAN Officer | -- | Direct | -- | May 23, 2024 |
| COWIE ROBIN HARPER Chief Financial Officer | Conversion of Exercise of derivative security at price 0.42 per share. | Direct | 1,768 | May 23, 2024 |
| PESTANO GARY ANTHONY Officer | -- | Direct | -- | May 23, 2024 |
| KENNEDY LAWRENCE T JR. Director and Beneficial Owner of more than 10% of a Class of Security | -- | Indirect | -- | May 23, 2024 |
Related Tickers
IDXG Interpace Biosciences, Inc.
1.0000
0.00%
CSTL Castle Biosciences, Inc.
20.93
-1.60%
ACRS Aclaris Therapeutics, Inc.
1.2700
+6.72%
300347.SZ Hangzhou Tigermed Consulting Co., Ltd
45.49
+0.35%
IJF.MU Icon PLC
124.85
+3.22%
603127.SS Joinn Laboratories(China)Co.,Ltd.
15.44
-0.96%
0RUG.IL bioMérieux S.A.
113.90
+0.26%
TN8.DE Thermo Fisher Scientific Inc.
372.55
-5.86%
ILU.F Illumina, Inc.
67.72
+1.38%
DIA.WA Diagnostyka S.A.
148.50
-2.17%